#oh but at current price for my biktarvy medicaid is paying 52736.28 per year

[sunflowers666]

trial sponsored by gilead.. "Lenacapavir is not a new drug. It’s been approved by the FDA in the United States for multi-drug resistant HIV treatment since 2022. But PURPOSE 1 is the first clinical trial to test it for HIV prevention." ... "Lenacapavir’s cost as HIV treatment in the United States in 2023 was $42,250 per new patient per year."

itd be cool if someone figured out how to steal it! its neat that its so long lasting nd injectable. id heard abt cabotegravir/rilpivirine which gets injected once monthly for HIV treatment, but i dont kno much else about it. apparently lenacapavir is a new mechanism than a lot of the other ones ive read abt which is interesting

This is a cool result: current oral PrEP requires a daily pill, but a trial of a twice-yearly injection of lenacapavir has proven so effective that the trial being conducted was ended early to give all participants the drug. Not only do twice-yearly injections avoid the problem of having to remember to take a pill every day, they also may have less stigma, which has been a problem for PrEP in the past.